PLoS ONE (Jan 2022)

Alarm of non-communicable disease in Iran: Kavar cohort profile, baseline and 18-month follow up results from a prospective population-based study in urban area.

  • Ali Reza Safarpour,
  • Mohammad Reza Fattahi,
  • Ramin Niknam,
  • Firoozeh Tarkesh,
  • Vahid Mohammadkarimi,
  • Shahrokh Sadeghi Boogar,
  • Elham Abbasi,
  • Firoozeh Abtahi,
  • Gholam Reza Sivandzadeh,
  • Fardad Ejtehadi,
  • Mohammad Afshar,
  • Seyed Ali Shamsnia,
  • Nasim Niknejad

DOI
https://doi.org/10.1371/journal.pone.0260227
Journal volume & issue
Vol. 17, no. 1
p. e0260227

Abstract

Read online

The PERSIAN Kavar cohort study (PKCS) aims to investigate the prevalence, trends, and relevant prognostic risk factors of non-communicable diseases in participants aged 35-70 years living in the urban area of Kavar County. Kavar County is located at the center of Fars province in the southwest of Iran. Overall, 5236 adults aged 35-70 years old were invited to participate in the PKCS. From whom, 4997 people comprising 2419 men and 2578 women met the inclusion criteria and were recruited in the study (participation rate: 95.4%). This study is aimed to follow participants for at least 10 years; it is designed to perform all procedures similar to the primary phase including biological sampling, laboratory tests, physical examinations, and collecting general, nutritional, and medical data at the 5th and 10th years of follow-up. In addition, participants are annually followed-up by phone to acquire data on the history of hospitalization, any major diagnosis or death. At the enrollment phase, trained interviewers were responsible for obtaining general, nutritional, and medical data utilizing a 482-item questionnaire. The results of the baseline phase of this study show that the overweight category was the most prevalent BMI category among the registered participants (n = 2005, 40.14%). Also, almost one-third of Kavar adult population suffered from metabolic syndrome at the baseline phase (n = 1664, 33.30%). The rate of eighteen-month follow-up response was 100% in the PKCS. Hypertension (n = 116, 2.32%), cardiovascular outcomes (n = 33, 0.66%), and diabetes (n = 32, 0.64%) were the most prevalent new-onset NCDs during eighteen months of follow-up in the participants.